Observing clinicians across the landscape of musculoskeletal care, I see the relentless effort poured into every consultation. Everyone is doing their best in the healthcare system, be that public or private, but as we know, the workload and complexity have increased. The total number of people living with an MSK disorder globally sits at approximately 1.68 billion representing a 95% increase in total cases since 1990 [1] and are on a trajectory to expand by more than half by 2050 [2]. While physiotherapists have significantly increased their scope of practice over the last 40 years, in particular into areas of practice that were historically occupied by medicine, how are we managing this continuing and increasingly challenging future? Recent research suggests that physiotherapists in the UK are struggling with burnout [3–6], work related stress [7] impacting on wellbeing resulting in moral distress and injury [8,9]. It appears that the profession is stretched holding the professional duties, roles, responsibilities and obligations in one hand and trying to adapt to growing and multiple patient, societal and system related influences in the other. This can make clinicians feel trapped, stagnant, and stuck in a healthcare system that itself is struggling to adapt.

In a way, we feel like we are on a treadmill, walking, running, even sprinting, but never getting anywhere.

Dave Nicholls captured our current predicament beautifully in his 2024 IFOMPT presentation in Basel, titled ‘The post-professional futures for the physical therapies’ [10]. He articulated the profound global and specific challenges facing our profession, pointing to three forces that are actively accelerating them: late-stage capitalism, the unbundling of expertise, and digital disruption. Dave asked penetrating questions about what comes next, concluding that we must uncover what truly lies beneath the surface of physical therapy. Only by doing so can we open up opportunities to adapt to this rapidly unravelling landscape.

Before we attempt to answer this question let’s briefly take a history of the present of MSK physiotherapy.

She was 25 and needed a hip replacement — how can we stop this happening?

Not the start to the week that I wanted.

One of my patients on Monday morning was just 25 years old. Chronic hip pain for over four years. Seen by multiple clinicians. Not picked up.

Hip dysplasia. Missed. Now progressed to severe osteoarthritis.

She’s missed the window for periacetabular osteotomy (PAO) surgery. Now she’s waiting for a hip replacement.

Twenty-five.

This case isn’t unique. And that’s precisely the problem. Kennedy et al. [1] found that the mean time from a patient presenting to their GP to finally being seen at a specialist young adult hip clinic was over 40 months. Those with delayed referrals had worse functional scores, higher radiological osteoarthritis grades, and were significantly more likely to require total hip arthroplasty rather than the joint-preserving periacetabular osteotomy that could have changed the trajectory of their condition entirely.

Gambling and Long [2] explored the psychosocial impact of this diagnostic delay in a study of 97 young adults with hip dysplasia. Seventy-five of them experienced a delayed diagnosis, with an average delay of eight years. Eight years of being told it’s muscular, it’s postural, it’ll settle with exercises. These patients became progressively more debilitated, experienced chronic pain, and reported a profound impact on their quality of life and psychological wellbeing.

As frontline MSK clinicians, we are often the first point of contact for these patients. We have the opportunity to change this. But only if we know what we’re looking for.

Here are five clinical pointers that should raise your index of suspicion for hip dysplasia, and the reasoning behind each one.

A community pilot reduced musculoskeletal waiting lists by 20%, and its reward was a national budget smaller than the pilot itself. The announcement, stripped of its press-release gloss, identifies an initiative that reduced community musculoskeletal waiting lists by a fifth that is now going national. The reward for that success is a grand total of £3.225m, which I had to read twice as I was expecting more zeros [1]. The pilot that proved the model in the first place cost £3.5m [2], so the reward it has earned, namely the budget to do exactly the same across every health system in England, is somehow smaller than the pilot that produced it.

A bit of backdrop before we get to the outrage - because the scale of it really does matter. Ill health now costs the UK economy somewhere in the region of £212bn a year, a figure published in last autumn’s Keep Britain Working Review and worth roughly seven per cent of GDP [3], and my dear old friend MSK sits second only to mental health among the drivers of that bill. MSKMag readers will know that musculoskeletal conditions affect nearly 18 million people in England [4] and account for somewhere between a fifth and a third of GP appointments, depending on whose figures you happen to trust [5]. They also make up the third largest area of NHS spend at around £5bn a year [6], so when you set the national rollout against that £212bn you land at roughly 0.0015 per cent of the problem, which is a rounding error for the Treasury.

Let’s be clear, none of this is a criticism of the work itself, which is genuinely very good. GIRFT’s MSK Community Delivery Programme cut eighteen-week community waits by twenty per cent across seventeen integrated care boards between December 2024 and March 2025 [7]. It did so with deeply unglamorous ingredients, namely community clinics, local clinical leadership and one-stop appointment days that bundle assessment, treatment, mental health support and physical activity into a single visit rather than scattering them across four separate letters and four separate days off. There is no miracle buried in any of this, just a sensible, joined up pathway run by the right people, close to where patients actually live.

I have a bit of skin in this game because I spent years involved in one-stop initiatives in orthopaedics and rheumatology, the very kind that GIRFT now references. Their simplicity was a key ingredient in why they worked, with patients seen, assessed, imaged and started on a plan inside a day instead of bouncing around the system for the better part of a year. The point worth holding onto is that the model is genuinely repeatable and translatable, which is to say it is not a clever local fluke that happened to work because of one brilliant clinical lead, it is a method and methods can be copied and scaled.

Which is exactly where it grates, because the seventeen-area pilot cost £3.5m and a second cohort of six more areas took another £2.2m [1]. In effect, the model has now been proved twice, across twenty-three systems and rewarded with a national budget of £3.225m to cover the entire country. England has forty-two Integrated Care Boards (ICBs) where the pilot areas received up to £300,000 each. The national rollout funding works out closer to £77,000 per area, which is roughly a third of what the trailblazers got to do precisely the same job [1]. The unspoken brief reads something like, “erm guys, can you do the same again, at scale, for less money than you spent the first time?” Anyone who has ever run a service will recognise both the request and the quiet despair this ignorance tends to produce.

The deeper problem sits underneath the budget line; in the workforce, and I talk about this a lot on my various channels because the gap is real and it is widening. Becoming a physiotherapist today means obtaining near-perfect grades, no meaningful tuition concession of the sort we used to offer, a brutal job market the moment you qualify and a salary that flattens inside a decade. Being good is no longer enough and there is constant pressure to specialise, or to extend scope, simply to stay relevant and employable. We have quietly turned (in my opinion) the single most cost-effective profession in healthcare into one of the least attractive to enter and then we act faintly surprised when the workforce pipeline starts to thin.

The opportunity here is enormous and it is worth being specific about why. The twenty per cent reduction was on the community list - the smaller and earlier queue, which is precisely what makes it exciting rather than marginal. Treat and mobilise people earlier in the community and you take pressure off the trauma and orthopaedics list further downstream, which remains the single largest elective queue in the country [8]. Keeping patients moving, at work, and off surgical waiting lists will reduce expensive problems in years to come. And those who do still need surgery will arrive in better physical and mental shape, which is a precursor for faster recovery, less time spent in hospital, and less cost to the system on the way through.

The model also does something rather neat which deserves more credit. By pulling movement and mental health into the same visit, it chips away at the two biggest contributors to that £212bn bill at the same time and movement (psst, it is rather good for the brain as well as the body). The link has been known for years but we simply do not commission or broadcast it as though we believe it.

If the system were serious - and by system I mean something rather more durable than a revolving door of health secretaries - it would do four fairly obvious things:

* It would fund the workforce in the tens of millions rather than the low single figures

* It would treat compliant hybrid digital MSK pathways as a genuine clinical priority, where the whole population can access at the front door.

* It would build in-house rather than reflexively buying off-the-shelf products to fill the gap. This is not complex tech and return on investment multiples when there are no licence fees going to external developers.

* It would actually scrutinise what it has already bought, because a surprising amount of tech has never been shown, independently, to do very much at all. Don’t get me started on a medical device’s defined intended use versus how it is being deployed in the system.

So here is where I keep landing as this issue travels a long way beyond MSK. We consistently mistake cost and complexity for value. The expensive, complicated, heavily branded intervention feels serious, so it gets the money and the contract. Meanwhile the cheap, simple, effective solutions are overlooked as if it cannot possibly be the answer. Pilots happen, credit ensues, yet the budget to achieve impact at scale never materialises. For me simple, good physiotherapy is affordable, effective and scalable. Its only real crime is that it is not shiny.

So I will leave you with the same question I opened with, because I’m yet to see a satisfying answer - if a pilot scheme can knock a fifth off the waiting list on a shoestring and proven its effectiveness across twenty-three areas, why on earth are we not throwing cash at it?

References

* GIRFT (2026) National rollout of GIRFT’s musculoskeletal (MSK) Community Delivery Programme, thanks to £3.2m government funding. gettingitrightfirsttime.co.uk

* GIRFT (2025) GIRFT starts work on £3.5m government programme to reduce waiting times for elective community MSK services. gettingitrightfirsttime.co.uk

* Keep Britain Working Review (2025) summary of the £212bn annual cost of ill-health economic inactivity, approximately 7% of GDP. economicsbydesign.com

* GOV.UK (2026) MSK patients to get faster care and help returning to work (MSK affects nearly 18 million people in England). gov.uk

* NHS England Musculoskeletal health (over 20 million people in the UK; up to 30% of GP consultations; over 30 million working days lost annually). england.nhs.uk

* Hansard, UK Parliament (2024), citing the Office for Health Improvement and Disparities: MSK conditions are the third largest area of NHS spend at around £5bn a year. hansard.parliament.uk

* GIRFT (2026) Evaluation shows MSK waiting lists reduced by 20% during GIRFT pilot. gettingitrightfirsttime.co.uk

* The King’s Fund (2025) Waiting Times for Elective (Non-Urgent) Treatment: Referral to Treatment (RTT) (trauma and orthopaedics has the largest specialty waiting list). kingsfund.org.uk

When was the last time you ate something without some input from a medical device? For me it was 2010. I was diagnosed with Type 1 diabetes aged 22 whilst seeing the GP for a UTI - which is quite undramatic as Type 1 diagnoses go. Since then, every meal starts with either a blood test or a look at the app screen of my continuous glucose monitor (CGM) and an injection of insulin. It is very easy to get this dose wrong given that some of the factors that can affect your blood glucose other than what you’ve just eaten include: stress, the temperature, illness, alcohol, certain medications, the stage of my menstrual cycle, and exercise. This doesn’t even come close to being an exhaustive list.

And so that is why one day, over a year ago, I inputted the word ‘FURY’ to my CGM after it alarmed on and off for a few hours whilst I tried to work, and a few weeks after that my consultant said “regular states of fury do suggest this might be impacting your mental health”, and a few months after that I ended up being approved for an insulin pump, for which I attended an education evening this week.

There are two means of delivering insulin to a Type 1 diabetic: multiple daily injections via a pen, or by an electrical device that attaches either directly to your skin or via a tube and cannula. The pump more accurately mimics the pancreas by drip feeding the dose of insulin over a period of hours. Cleverly, pumps now also communicate with CGMs and can (alongside occasional human input) use a rising or falling blood glucose reading to help keep you in range.

One does not simply get an insulin pump. Some Type 1s prefer the idea of pens to being stuck to another medical device. Others have to meet the eligibility criteria for funding. The criteria where I live involves a specific HbA1C blood test reading that suggests your blood glucose control could be better (which I don’t meet), considering pregnancy (nope), or that regular hypos are impacting your mental health. Well just ask 7 out of 10 of my post-prandial patients about that while I shove precisely eight Haribo Goldbears down my neck. I qualify.

What that criteria doesn’t take into account though is what I was seeing in my own diabetes management. The slow creep upwards of my HbA1C alongside a level of burnout that’s impossible to quantify on a blood test but is directly related to sixteen years of mental arithmetic and option weighing before and after every meal, sleep and bout of exercise. I’m not in crisis, I’m just tired, and unspectacularly getting worse at this full time job of sixteen years. And yet the thing that might help is not widely available.

Which is, funnily enough, a theme running through this month’s MSKMag. In his article The Biggest Wins in the NHS are Cheap, Luke Kellaway explores why lower cost, efficiency-boosting programmes get reduced funding versus costly, complex interventions. Just as prevention and glucose management doesn’t shout the way a crisis does, neither does a smoothly running MSK pilot that reduces waiting times.

Meanwhile, Chloe Wearmouth issues a plea for more thought to be given to Paediatric services where all manner of presentations and specialties are shoehorned into one catch-all Paeds department in The Forgotten Child of MSK.

Benoy Mathew shares insight of a presentation that can drastically change a patient’s outcome if we sit on it too long. Read The Diagnosis that Keeps Getting Missed: Adult Hip Dysplasia and avoid hip replacements in the young.

In her article Beyond the Bump: Reframing High-Grade AC Joint Injury, Angela Cadogan highlights the value of looking beyond simply strapping up the ACJ and getting on with it in her advice-packed piece covering ACJ rehab.

And finally, a philosophical viewpoint from Matthew Low in Off the Treadmill, Into the Field, which asks us to stop thinking about the body as a fixed thing that occasionally breaks, and start thinking about it as a process that never stops moving. Matthew suggests that a patient isn’t a stable object briefly interrupted by injury, but a flow of circulation, metabolism and circadian rhythm that clinicians step into and move alongside for a while.

Folks, I have been living this for sixteen years: I just didn’t have the word for it. My blood glucose is not a problem I fixed in 2010 and have been managing ever since. It is a flow that moves with every meal, every goal Newcastle United score or miss, and sometimes for no apparent reason at all. It never pauses to let me get it right and then leaves me alone. There is no version of me that is ‘fixed’. There is only a version of me that is in closer or looser conversation with it, hour to hour, and a pump is simply a slightly better way of me getting a word in edgeways.

Which perhaps is the real case for funding the insulin pump, the pilot scheme, the paediatric service or the properly rehabbed AC joint before crisis point: not because it fixes anything once and for all, but because bodies, like health systems, don’t hold still long enough to be solved. They only ever get better tended, or worse neglected.

Consider this issue your own insulin pump education evening without the need to self-cannulate: five articles on the difference between fixing and tending, between waiting for crisis and listening for the creep. I hope by the end that you’ll feel just a little more in-range.

A 24-year-old middle distance runner came in with dorsal midfoot pain – just distal to a little lump at the dorsal talonavicular joint.

By the time she reached me she’d done the full lap. Foot strengthening. Mobilisations. Expensive custom orthotics. Shockwave. Dry needling. None of it moved the needle.

Her running told the same story every time. Fine off the line but pain starting 2 to 3 km into a 5 km run. Every session.

She’d already had an MRI from a previous healthcare provider.

In a classic case of ‘junk in = junk out’ - there wasn’t much on the report.

The referral: ‘ankle pain’, though ideally it would have read ‘dorsal midfoot in runner near palpable prominence at talonavicular joint’.

C’mon people…. Radiologists deserve some stories sometimes!

Despite an allegedly radiologically-boring midfoot, the report did give away the big clue in the hindfoot: an osseous subtalar tarsal coalition across the sustentaculum tali (without significant stress reaction).

Nobody paid it much attention, presumably because nobody was sure what it meant.

The beak is a symptom, not a diagnosis

A dorsal talar beak is a bony outgrowth on the upper aspect of the talar head, projecting toward the talonavicular joint. It is a traction osteophyte.

It forms where the dorsal talonavicular ligament and capsule pull repeatedly on the talus; the foot’s attempt to remodel around mechanics that have gone wrong upstream [1].

The alternative explanation is mechanical: the navicular rides up over the talar head and lifts the periosteum, and bone fills the gap [2].

Either way, the beak is not the villain, it is the breadcrumb.

The question worth asking is what is driving it. In a young adult the answer is often a restricted subtalar joint, and the usual culprit is tarsal coalition.

What a coalition actually is

As testosterone injections become normalised for strength, physique and recovery, emerging research is raising uncomfortable questions about injuries to ligaments, tendons and surgical repairs.

Testosterone has had a rebrand.

For many people, it no longer seems to sit in the same mental category as ‘performance-enhancing drug’ or ‘anabolic steroid’. It has become wellness-adjacent. Gym-adjacent. Recovery-adjacent.

More muscle. Better physique. Faster recovery. More confidence. Back in the gym sooner.

Sounds neat.

Until the ACL goes.

Or the Achilles. Or the biceps tendon. Or the rotator cuff.

This is the bit of the testosterone conversation that feels strangely quiet. The online discussion often starts and ends with body composition, energy, libido and performance. But for those of us working in musculoskeletal practice, there is another question worth asking.

What is happening to the tissues that have to tolerate all this extra force?

In May 2026, the British Medical Association, the largest doctors’ union in the UK, published the findings of a survey of over 5,000 doctors on the role of Advanced Practitioners (APs), with 81% saying that the way APs currently work poses a risk to patient safety. This was reflected in a new position statement from the Royal College of Physicians, suggesting that replacing doctors with other roles created ‘a real risk of fragmented care and harm to patient safety’.

To understand the degree of antipathy against APs, we must go back to the beginning (This is where, in a film, the swirly spiral denotes we are going back in time (you can hum the atmospheric tune yourselves…)).

The Origin Story

It’s the millennium, and there is a steady but unmistakable shift from a model of care that was in place from the inception of the NHS in the 1940s to when I qualified in the early 2000s. The 1-in-2 on-call rotas are rapidly becoming a thing of the past as Modernising Medical Careers and the European Working Time Directive from 2004 onwards reduced the average number of hours worked by doctors and the old ‘firm’ structures (Consultant, Registrar, SHO, HO etc) made way for newer ways of working.

Whilst the number of hours doctors worked decreased, the population continued to age and grow, creating a tidal wave of increasing complexity and acuity, placing services under unprecedented demand. The number of patients registered with NHS GPs in England grew significantly, from roughly 50 million in 2020 to just under 64 million by 2025.

To meet this growing demand, the Health Foundation suggests that a further 3,500 GPs will be needed by 2031. But it takes a long time to train a doctor; 10+ years as a minimum for GPs, and the number of full-time equivalent GPs has dropped by 458 since 2015.

Step into the breach: non-doctor roles. By the time of the NHS long-term plan in 2019, early pilots of first-contact physiotherapists had shown they could be useful members of the primary care team. In 2020, the National Evaluation of the First Contact Practitioner (FCP) model of primary care evaluated 240 FCPs from 40 services in England and found that FCPs were acceptable to patients, produced positive outcomes, and reduced GP workload [1].

Are physiotherapy graduates ready for practice? If you’ve ever asked this question, you’re not alone.

The quick answer? No. But they’re not meant to be.

The longer answer? Well that starts in 1894…

The Start of Physiotherapy Education

[Image 1: Almeric Paget Military Massage Corps [8]]

Four women drew a line. Stories in the national press were warning the public about ‘unscrupulous’ people offering massage as cover for something else entirely. They set up the Society of Trained Masseuses because the work deserved better. They established a curriculum and examinations. Standards mattered from the very beginning.

What followed was a profession that proved itself through necessity. When World War I broke out in 1914, physiotherapists were quickly deployed to military hospitals. They went where the need was greatest.

This community instinct, going where people are and working in the places where health matters, was not a policy position. It was simply what the profession did.

Recognition followed practice: it always has.

So, what does ‘being ready’ really mean for a profession that has always gone where people needed it, and found a different answer every time?

Ownership

In its earliest years, the physiotherapy classroom and clinic were never far apart. Learning happened close to the work, even without a formal structure.

By 1955 that structure arrived in the form of a national syllabus for physiotherapy [1]. Every UK student physiotherapist followed this one pathway - a three-year curriculum taking place in schools attached to a hospital. After an initial six months of training, they spent 1,500 hours or more treating patients under the supervision of qualified physiotherapists, accounting for 10-30 contact hours a week. The final exams were entirely practical, and they assessed and treated patients in the hospital. Assessment papers were sent directly to the professional body to be moderated against a national standard.

There was no gap between education and practice because the two had never been separated, everything taking place under one roof.

[Image 2: 1955 CSP Syllabus [1]]

Interestingly, the syllabus described the preparation of students as “a graduated process of education leading to admission to membership.“ Not admission to a qualification, but admission to a community. To qualify was to join. The professional body set the standards, ran the examinations, and held the membership. Regulation and professional identity were, in practice, the same thing.

Chewy and Jim are back - the lads were evaporating during the recording this month as the weather matched their opinions for heat…

Chewy and Jim is best watched in full via the video above (so you can watch them melt in real time) or you can listen on the usual podcast players.

In this recording, Chewy and Jim cover consultations from good to bad and their experiences sitting on both sides.

“You can be as good medically or with your assessment as you want, but if you can’t guide the consultation and keep the patient on board and engaged, they’re going to leave unhappy and not getting what they want out of it.” - Jim

It’s a real skill to run an effective consultation and this becomes really challenging in situations of complexity or system restrictions (lack of time). Unfortunately when this skill is lacking or not applied, the whole thing falls apart and people leave disappointed and frustrated. Chewy and Jim describe stark contrasts between well run and poorly run consultations and it makes a huge difference to the experience.

“The actual technical aspect of conducting a consultation is a really overlooked skill.” - Jim

Chewy and Jim get into a discussion about the variables that go into this particular skill and it is not just experience. Appropriate feedback mechanisms, training, and practice are all of vital importance to develop the ability to run the consultation effectively AND sensitively. Without appropriate challenge for poor practice and ongoing complacency that this is not a skill that requires development, variation in practice widens and can cause significant problems for those people attempting to navigate the health systems they require.

“Variation in care standards can be refined. It shouldn’t just be accepted that sometimes you get the biscuit muncher and sometimes you get the brilliant clinician.” - Chewy

This is a really difficult skill to improve and we will never master it fully; different components of it require work for individuals, Chewy for example never shuts up and Jim can’t wait to end every conversation as quickly as possible… Embracing your own individuality but holding it to within appropriate professional boundaries is the balance to aim for. Never go full Chew!

Jim points out that the likely training method for working on this skill is roleplay and that induces massive cringe responses in most but it is an absolute necessity in order to receive instant peer feedback and implement improvements outside of the clinic room that you can take with you. Embrace it and leave your cringe at the door: improvements in this skillset will help every aspect of the clinical consultation including the outcomes.

Chewy and Jim are nothing if not desperate for these rants to be clinically applicable tomorrow…

Dos and Don’ts for consultations:

* Introduce yourself and explain your role/Don’t leave patients guessing who you are.

* Set expectations early.

* Guide the conversation without being rude/Don’t interrupt abruptly.

* Don’t start the consultation distracted or disengaged.

Would Chew Rather speak only in technical jargon or only in complete lay language? The answer will likely surprise you… Let us know your answer.

If you have any ‘Would Chew Rather?’ or ‘Who Are Chew?’ questions put them in the comments or email them to us [email protected]

With cases from Dr James Noake

In musculoskeletal medicine, we are trained to recognise patterns. Most of the time, the answer sits comfortably within the familiar: overload, strain, tendinopathy. But every so often, something doesn’t quite fit. The story is slightly off, the response to treatment unexpected, or the clinical picture just a little too inconsistent.

This is where the ‘Zebra Farm’ comes in.

Each time, we explore a trio of real-world cases as written up by Dr James Noake (Consultant in Musculoskeletal, Sport and Exercise Medicine) in his upcoming book ‘Real World Sports Medicine and Musculoskeletal Case Studies : Knee and Lower Leg’. The cases challenge diagnostic instinct; presentations that look routine on the surface but reveal something far less obvious underneath. These are not just rare conditions for rarity’s sake; they are reminders of the cognitive traps we all fall into: anchoring, pattern recognition bias, and premature closure.

Because sometimes, when you hear hoofbeats, it isn’t a horse.

This is the Zebra Farm.

Case 1: The ‘Compartment Syndrome’ That Wasn’t - Myotonia Congenita

A runner and footballer in their late 20s had endured a 10-year history of bilateral lower leg pain, described as ‘crampy’ and ‘bursting’.

Everything pointed toward chronic exertional compartment syndrome (CECS):

* Rapid symptom onset with running

* Involvement of multiple compartments (anterior worst)

* Stiffness and subjective weakness after activity

They had even undergone bilateral fasciotomies with no improvement.

Something didn’t add up

On reassessment:

* Muscles felt ‘woody’ and rigid post-exercise

* There was increased muscle tone noted and delayed muscle relaxation

* Power improved paradoxically with repeated effort

* MRI showed diffuse calf oedema bilaterally, but nothing focal

The crucial clue came from EMG:

* Myotonic discharges producing a classic ‘dive-bomber’ sound

* Further testing showed mild changes in the deltoid too

Diagnosis: Myotonia Congenita

A non-dystrophic neuromuscular disorder - not a compartment problem at all.

Why it fooled everyone

* The patient looked ‘muscular’ (due to doing isometrics 24/7 for 10 years…)

* Imaging looked ‘consistent’ with exertional pathology

* Long history reinforced diagnostic anchoring

Key sign

➡️Symptoms didn’t fully settle after stopping exercise and they improved with repetition (warm-up phenomenon). Note though that this warm up phenomenon is short lived!

Transition: When ‘muscle pain’ isn’t muscle at all

The first case teaches us that abnormal muscle physiology can masquerade as mechanical overload.

The next case pushes this even further: when the pain isn’t muscular at all, but vascular.

Case 2: The ‘Nerve Entrapment’ That Was a Clot - Peroneal Vein Thrombosis

A patient in their 40s presented with 3 months of deep lateral calf aching:

* Worse with activity—but now present at rest and at night

* Localised toward the lateral calf

* Referred as possible superficial peroneal nerve entrapment

They also had a significant history:

* Prior contralateral DVT

* Avascular necrosis of the hip

The imaging changed everything

MRI neurography revealed:

* Marked oedema in the flexor hallucis longus region

* Oedema centred around the peroneal vessels

This raised suspicion of something non-mechanical.

➡️ Duplex ultrasound confirmed a peroneal vein thrombosis

Diagnosis: Deep vein thrombosis mimicking MSK pain

Why it fooled clinicians

* Localised lateral calf pain suggested nerve pathology

* Gradual onset, not acute

Key sign

➡️ Pain that progresses from activity-related to constant, especially with night pain, should raise suspicion

Bigger picture

This case also highlights underlying systemic risk:

* With recurrent thrombosis and AVN, consider possible antiphospholipid syndrome / Systemic lupus erythematosus (SLE)

Transition: When imaging is subtle - but the symptoms are loud

The first case was metabolic.The second was vascular.

The third returns to muscle but challenges our understanding of what a ‘muscle injury’ actually looks like.

Case 3: The ‘Imminent Tear’ - Soleus Central Tendon Injury

A runner presented with:

* 3 months of deep mid-calf aching

* Described repeatedly as an ‘imminent tear’ sensation following cramping

* No single traumatic event

* Performance and speed limited and runner has to pull up and stop when symptoms appear

Clinical pattern

* Low-level activity: manageable

* Threshold reached → sudden escalation of pain

* No bruising, no classic tear presentation

Imaging findings

* Ultrasound: Soleus central tendon injury with loss of definition and subtle hypoechoic changes

* MRI: central tendon (aponeurotic) disruption within the soleus

Diagnosis: Soleus central tendon injury

Why it fooled clinicians

* No ‘pop’ or obvious tear

* Minimal early clinical signs

* Ultrasound sensitivity is poor (~27%)

* Symptoms felt disproportionate to findings

Key sign

➡️ Deep, progressive calf pain with a ‘threshold’ or ‘pre-tear’ sensation - without trauma

Closing Reflection: Patterns That Should Make You Pause

These three cases highlight a shared clinical truth:

When the pattern doesn’t behave like a simple strain, it probably isn’t.

Across all three:

* Symptoms persisted beyond expected timelines

* Pain behaviour was atypical

* Initial diagnoses seemed plausible - but incomplete

The real challenge isn’t recognising rare diagnoses, it’s recognising when a common diagnosis no longer fits.

Practical Takeaways

Red flags in ‘routine’ calf pain

* Night pain or symptoms at rest

* Bilateral or multi-compartment involvement

* Long-standing symptoms with failed standard treatment

* Disproportionate stiffness or muscle tone

* Neurological or systemic history

Think beyond muscle when:

* Symptoms don’t resolve after rest (≠ CECS pattern)

* Pain improves with repetition but only for a short time (→ myotonia)

* Symptoms progress despite offloading

* Pattern is inconsistent with imaging

Always consider alternatives:

* Neuromuscular → myotonia, metabolic myopathies

* Vascular → DVT, post-thrombotic syndrome

* Aponeurotic/tendon → deep muscle architecture injuries

Clinical mindset shift

* Don’t anchor on the first ‘reasonable’ diagnosis

* Reassess when treatment fails

* Let pain behaviour, not just imaging, guide your thinking

In MSK medicine, the sound of hooves is usually a horse.

But in calf pain- it’s just often enough a zebra to matter.